Bibliography

Geral

cost-effectiveness of managing HIV infection.pdf
Cancer Risk in ID, smoke and HAART.pdf
european guidelines for the clinical management.pdf
hivmedicine2007.pdf
Measuring effectiviness in community randomized trials of HIV prevention.pdf
THE CARE OF HIV-INFECTED ADULTS IN THE UNITED STATES.pdf
Assistência a doentes VIH-SIDA.pdf
Infecção pelo VIH.pdf
Internamento.pdf
Tratamento.pdf
Avaliação nutricional.pdf

CNSida

Centro de Vigilância Epidemiológica.pdf
Contratualização Infecção VIH-Sida.pdf
eurobarómetro.pdf
HIV_AIDS surveillance.pdf
manual boas práticas.pdf
manual boas práticas farmácia hospitalar 08.pdf
manual boas práticas farmácia hospitalar 2008.pdf
PROGRAMA NACIONAL.pdf
Rec Portuguesas Tratamento.pdf
Rede de Referenciação Hospitalar.pdf
Relatório de Actividades 2006.pdf (Em falta, ficheiro superior a 10Mb)

Incidência e Prevalência

HIV prevalence and incidence.pdf
unaids global report.pdf
A situação em portugal a 31 dez-sida.pt.pdf
PALOP.pdf
Portugal 2008.pdf
National Probability SamplesI.pdf
National Probability SamplesII.pdf
A Two Stage Sampling Method.pdf

Terapêutica anti-retrovírica

1. rate of virologic failure.pdf
5. increased risk of virologic failure.pdf
6. Recommendations of the International AIDS Antiretroviral Treatment of Adult HIV Infection 2008.pdf
7. Characterization of Virologic Failure After an Initially Successful 48-Week Course of Antiretroviral Therapy in HIV.pdf
9. Incidence and Predictors of Virologic Failure of Antiretroviral Triple-Drug Therapy in a Community-Based Cohort.pdf
11. Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy.pdf
12. Predictors of Antiretroviral Treatment Failure.pdf
clinical outcome and predictive factors of failure of HAART.pdf
effects of HAART on Health Status and Hospital Costs.pdf
Emergence of Drug Resistance Is Associated.pdf
evolving patterns of HIV-1 resistance AIDS 2002_16.pdf
Long-term effectivness of HAART.pdf
Mortality_and_progression_to_AIDS_after_starting.11.pdf
pharmtable.pdf
predictors of HIV Drug-Resistance J Inf Dis 2005.pdf
predictors of virological success and ensuing.pdf
prevalence antiretroviral drug resistance.pdf
prognosis of hiv-1 infected patients starting.pdf
the prevalence of antiretroviral drug resistance AIDS 2004.pdf
WHO ART recommendations 2006.pdf
Antiretroviral Treatment of Adult HIV Infection 2008 recommendations.pdf
HIV therapy guidelides who.pdf

Padrão de Prescrição

Patterns of antiretroviral use in the USA - analysis of three observational databases.pdf
Differences in Prescription of Antiretroviral Therapy in a Large.pdf
Relationship Between Antiretroviral Prescribing Patterns and Treatment Guidelines.pdf
Evolution of Antiretroviral Prescription and Response over a Period of 8years - an Italian Multicentric Observational Prospective Cohort Study.PDF
Modeling the Impact of Antiretroviral Use in Developing Countries.pdf
AidsPortugal - IMPACTE DA TERAPÊUTICA ANTI-RETROVÍRICA DE ALTA POTÊNCIA NA ACTIVIDADE HOSPITALAREXPERIÊNCIA DO HOSPITAL DE EGAS MONIZ.doc

Adesão

adhrence to long term therapies evidence for action.pdf
3. Not All Missed Doses Are the Same.pdf
Adherence to Nonnucleoside Reverse Transcriptase Inhibitor–Based.pdf
adherence to protease inhibitor therapy and outcomes in HIV infection.pdf
adherence to protease inhibitor therapy and outcomes in HIV infection_correction.pdf
adherence to treatment in Swedish HIV infected patients.pdf
Attitudes Toward Health Care Providers.pdf
Barriers to HAART adherence.pdf
Best Practice for adherence.pdf
changes in adherence AIDS 2004.pdf
chesney_adherence to HIV therapy_soc sci med.pdf
determinants of heterogenous adherence.pdf
Intermittent use of triple combination therapy.pdf
Intermittent_antiretroviral_therapy_in_patients.8.pdf
Longitudinal Antiretroviral Adherence Among adolescents.pdf
long-term patient adherence AnnPharmacother 2000.pdf
Non-compliance with drug dosing regimens.pdf
Outpatient pharmacy care and HIV viral load response.pdf
Report on Medication Adherence_WHO 2003.pdf
selective drug taking.pdf
the CASE adherence index AIDS Care 2006.pdf
The_Association_of_Adherence_to_Antiretroviral_Therapy_with_Healthcare_Utilization_and_Costs_for_Medical_Care.pdf
variations in patterns of HAART adherence.pdf
Theses from Uppsala University 7282 - Adherence and Readiness to Antiretroviral Treatment.mht
Time to discontinuation of the first highly active antiretro___ AIDS.txt

Métodos

4. long-term utility.pdf
electronic monitoring_adherence assessment or intervention.pdf
Patient and provider reported adherence.pdf
picrender.pdf
Self-report non-adherence.pdf
self-reporting.pdf
MSM.pdf

Factores associados

10. Cross-Sectional Study to Evaluate Factors Associated with Adherence to Antiretroviral Therapy by Brazilian HIV-Infected Patients.pdf
Differences in adherence and motivation to HIV therapy.pdf
Durability_of_Adherence_to_Antiretroviral_Therapy_on_Initial_and_Subsequent_Regimens.pdf
factors affecting patient adherence AnnPharmacother 2003.pdf
Insights_into_the_reasons_for_discontinuation_of.5.pdf
Literacy and HAART adherence.pdf
patients' perceptions.pdf
patterns and predictors of changes in adherence.pdf
patterns of adherence to antiretoviral medications AIDS2003.pdf
Patterns_and_Correlates_of_Discontinuation_of_the.8.pdf
Reasons_for_modification_and_discontinuation_of.7.pdf
Varíaveis associadas à adesão à TAR.pdf

Implicações

2. future implications Compliance and failure.pdf
8. A Simple, Dynamic Measure of Antiretroviral Therapy Adherence Predicts Failure to Maintain HIV-1 Suppression.pdf
13. Relationship between adherence level type of the antiretroviral regimen and plasma HIV type 1 RNA viral load.pdf
association between adherence_drug resistance.pdf
Balancing Adherence Concerns with the Risks of HIV Disease Progression.pdf
four measures of antiretroviral medication adherence.pdf
the consistency of adherence to antiretroviral therapy predicts biologic outcomes.pdf

Mudança

Impact of drug classes and treatment availability on the rate of ART change.pdf
Insights into the reasons for discontinuation of the firts HAART regimen.pdf
Primera pauta de tratamiento antirretroviral.pdf
Starting or Changing Therapy[1].pdf
Successes, challenges, and limitations of current ART.pdf
The creation of a large UK-based multicentre cohort of HIV-infected individuals The UK Collaborative HIV Cohort.pdf
Treatment switches after viral rebound in HIV infected adults starting antiretroviral therapy multicentre cohort study.pdf
Resistance analysis in HIV infected with multiple ART treatment.pdf
Prevalence and correlates of HAART switching.pdf
Patterns and correlates of discontinuation of the initial HAART regimen.pdf
National review of 1st change after starting HAART.pdf
Effect_of_Switching_on_Persistence_statins.pdf
National_review_of_first_treatment_change_after_starting_highly_active_antiretroviral_therapy_in_antiretroviral_naive_patients.pdf
Stages of Change for Adherence.pdf
Treatment_switches_after_viral_rebound_in.6.pdf
Incidence of Discontinuation of Highly Active Antiretroviral Combination Therapy (HAART) and Its Determinants

TERAPÊUTICA DE DOENTES VIH EM AMBULATÓRIO NO HOSPITAL MILITAR DE BELÉM - ESTUDO RETROSPECTIVO

Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License